U.S. Markets closed

Strength Seen in ZIOPHARM Oncology (ZIOP): Stock Up 11.8%

Zacks Equity Research

ZIOPHARM Oncology, Inc. (ZIOP) was a big mover last session, as the company saw its shares rise nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.10 to $4.64 in the past one-month time frame.

The company has seen one positive estimate revision over the past 30 days, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

ZIOPHARM currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Investors interested in the medical industry may consider stocks like ANI Pharmaceuticals, Inc. (ANIP), Alexion Pharmaceuticals, Inc. (ALXN) and Alkermes plc (ALKS). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ZIOPHARM ONCOLOGY INC (ZIOP): Free Stock Analysis Report

ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report


ALKERMES PLC ORD (ALKS): Free Stock Analysis Report

Zacks Investment Research